A big boost for public health
Unlike polio and smallpox, the risk of maternal and neonatal tetanus
will always exist. Tetanus spores are always a part of the environment.
Thus ‘elimination’ must be seen as an enduring pursuit.
Maternal and neonatal tetanus (MNT) is no longer a major public health
problem in the World Health Organisation (WHO) South-East Asia region.
The WHO South-East Asia Region has eliminated MNT as a major public
health problem.As immunisation coverage and access to maternal and
newborn health care has increased, the number of mothers and newborns
suffering agonising deaths on account of the disease has declined to
below one in every 1,000 live births at the district level. This is a
major achievement.
In 1989, when the fight against neonatal tetanus (and, consequently,
maternal tetanus) began, tetanus toxins were claiming the lives of
approximately 7,87,000 newborns across the world. Unhygienic conditions
during delivery and inadequate umbilical cord care saw to it that these
toxins could infect mother and child, causing muscle spasms, lockjaw,
and often death.
With recent elimination successes in India and Indonesia, the South-East Asia region has reached a milestone.
Though elimination took longer than expected, it is a victory that must
be savoured. At the same time, however, it is a victory that is by no
means final.
Unlike the situation with diseases such as polio and smallpox, the risk
of MNT will always exist. Tetanus spores are always a permanent part of
the environment, meaning public health setbacks could once again
compromise mothers and their newborns. In relation to MNT, “elimination”
must be seen as an enduring pursuit.
Strengthening measures that facilitated elimination in the first
instance can best guarantee the ongoing safety of mothers and their
newborns.
Innovative strategies
Sustaining and enhancing access to quality maternal and newborn health
care is critical. By providing expectant mothers the ability to access
quality antenatal and safe-birthing services, health systems throughout
the region diminish the risk of tetanus infection, as well as other
potentially lethal complications. Though countries in the region have
made important gains have been made in the region, the momentum must be
accelerated. There must be innovative strategies deployed to reach those
‘unreached’, such as increased training of skilled birth attendants at
community-level facilities, or providing cash transfers to every mother
who has an institutional delivery, for example.
Immunisation coverage must be maintained and enhanced. Expectant mothers
must receive the necessary tetanus toxoid vaccine, or combination
vaccine, as a matter of priority and at the appropriate stages of
pregnancy.
As Indonesia’s campaign to vaccinate brides-to-be demonstrates that
positive initiatives need not be confined to the pregnancy or neonatal
periods. Just as newborns receive tetanus immunisations as part of their
routine immunisation schedule, children must receive booster doses as
and when appropriate. A good place for this to happen is at school.
Despite the region’s newly validated status, health authorities must
ensure that preventing maternal and neonatal tetanus remains prominent
on the list of vaccine-preventable diseases, and that opportunities to
immunise against tetanus are grasped.
Effective engagement with communities is essential. Communities that
have difficulties accessing care or which lack experience doing so must
be further encouraged to avail themselves of the benefits maternal and
newborn health care brings. Messages related to tetanus immunisation and
safe-birthing must remain integrated with other outreach activities,
and disseminated among the most vulnerable. Harmful traditional
practices should be discouraged, while at the same time continuing to
build relationships that promote trust, respect and inclusiveness.
A positive experience with health care providers can have far-ranging effect, not only for an individual but also a community.
Tracking progress
A robust and effective surveillance system is vital to tracking progress
in these key areas. After all, the failure of any one of them can mean
the death of a mother or newborn through tetanus infection. By closely
monitoring incidences ofMNT, authorities can evaluate the impact of
their efforts, and, if found lacking, better calibrate them in future.
In-depth knowledge of the causes of every case of maternal or neonatal
tetanus, combined with a resolve to ensure it is not repeated, can be
the only appropriate response. However great the recent achievement is,
it remains unacceptable that any woman or child should suffer the
devastating disease.
Along with conducting routine vaccine-preventable disease surveillance,
WHO is committed to realising the unfinished Millennium Development Goal
agenda as it relates to maternal and newborn health, which will in turn
help allay tetanus’s menace. Efforts to achieve Universal Health
Coverage — a priority area of WHO in the South-East Asia region — will
similarly enhance health equity, ensuring that tetanus’s tendency to
prey on the most vulnerable is rebuffed. It is no coincidence that the
first countries in the region to eliminate the problem also had the
strongest health systems.
That MNT has been eliminated as a major public health problem in the South-East Asia region is reason to celebrate.
Newborns across the region are now safer from the disease than at any
other time in history, but we must not be misled by our successes.
Maternal and neonatal tetanus remains a burden, and could make a
comeback in significant numbers in future. By enhancing the reach and
quality of maternal and newborn health care, increasing immuniSation
coverage, leveraging greater community buy-in, and ensuring detailed
surveillance, we can avert this possibility.